# CREXONT

NDC: 64896-970
Generic name: carbidopa and levodopa
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20240809

FDA application: NDA217186

## Active ingredients

- CARBIDOPA HYDRATE: 87.5 mg/1
- LEVODOPA: 350 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64896-970"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64896-970
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=095a08b6-b0b8-4f88-b759-67e8b87287a0